Company Filing History:
Years Active: 2008
Title: Mathew C Coffey: Innovator in Reovirus Production
Introduction
Mathew C Coffey is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of virology, particularly in the production of infectious reovirus. His innovative methods have the potential to enhance research and therapeutic applications involving this virus.
Latest Patents
Mathew C Coffey holds a patent for a method of producing infectious reovirus. This patent describes a simple and efficient technique for producing mammalian reovirus using HEK 293 cells. The method allows for fast production of reovirus in high yield, which is crucial for various applications in research and medicine. Additionally, it simplifies the purification procedure of the produced reovirus, making it more accessible for further studies.
Career Highlights
Coffey is associated with Oncolytics Biotech Inc., a company focused on developing innovative cancer therapies. His work at the company has been instrumental in advancing the understanding and application of reovirus in oncology. His expertise and dedication to research have positioned him as a key figure in the field.
Collaborations
Mathew C Coffey collaborates with various professionals in his field, including his coworker, Bradley G Thompson. These collaborations enhance the research efforts and contribute to the development of effective therapeutic strategies.
Conclusion
Mathew C Coffey's contributions to the production of infectious reovirus represent a significant advancement in virology. His innovative methods and dedication to research continue to impact the field positively.